Comparative Efficacy and Safety of Ultra-Long-Acting, Long-Acting, Intermediate-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: a Systematic Review and Network Meta-Analysis
Keyword(s):
2017 ◽
Vol 129
◽
pp. 213-223
◽
Keyword(s):
2020 ◽
Vol 19
(1)
◽
pp. 545-550
Keyword(s):
2017 ◽
Vol 79
(6)
◽
pp. 684-696
◽
Keyword(s):
Keyword(s):
2020 ◽
Keyword(s):
2020 ◽
Keyword(s):
2020 ◽
Keyword(s):